Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Opzoomer JW"'
Autor:
De Jonghe J; Francis Crick Institute, London, UK., Opzoomer JW; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London, UK.; Relation Therapeutics, London, UK., Vilas-Zornoza A; Relation Therapeutics, London, UK., Crane P; Caeruleus Genomics, Oxford, UK., Nilges BS; OMAPiX GmbH, Langenfeld, Germany., Vicari M; Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden., Lee H; spatialist AB, Stockholm, Sweden.; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden., Lara-Astiaso D; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Hematology, University of Cambridge, Cambridge, UK., Gross T; Relation Therapeutics, London, UK., Morf J; Skyhawk Therapeutics, Basel, Switzerland., Schneider K; Roche, Basel, Switzerland., Cudini J; Relation Therapeutics, London, UK., Ramos-Mucci L; Relation Therapeutics, London, UK., Mooijman D; Single Cell Discoveries, Utrecht, the Netherlands., Tiklová K; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden., Salas SM; spatialist AB, Stockholm, Sweden.; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden., Langseth CM; spatialist AB, Stockholm, Sweden.; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden., Kashikar ND; OMAPiX GmbH, Langenfeld, Germany., Roberts CES; Relation Therapeutics, London, UK.; ARK Investment Management, St. Petersburg, FL, USA., Lundeberg J; Science for Life Laboratory, Department of Gene Technology, KTH Royal Institute of Technology, Solna, Sweden., Nilsson M; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden., Shalek AK; Relation Therapeutics, London, UK.; Institute for Medical Engineering and Science, Department of Chemistry and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA., Cribbs AP; Caeruleus Genomics, Oxford, UK.; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, National Institute of Health Research Oxford Biomedical Research Unit (BRU), University of Oxford, Oxford, UK.; Oxford Centre for Translational Myeloma Research University of Oxford, Oxford, UK., Taylor-King JP; Relation Therapeutics, London, UK. jake@relationrx.com.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2024 Jul; Vol. 42 (7), pp. 1017-1023.
Autor:
Ramos Zapatero M; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Tong A; Department of Computer Science, Yale University, New Haven, CT, USA; Department of Computer Science and Operations Research, Université de Montréal, Montreal, QC, Canada; Mila - Quebec AI Institute, Montréal, QC, Canada., Opzoomer JW; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., O'Sullivan R; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Cardoso Rodriguez F; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Sufi J; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Vlckova P; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Nattress C; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Qin X; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Claus J; Phospho Biomedical Animation, The Greenhouse Studio 6, London N17 9QU, UK., Hochhauser D; Drug-DNA Interactions Group, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK., Krishnaswamy S; Department of Computer Science, Yale University, New Haven, CT, USA; Department of Genetics, Yale University, New Haven, CT, USA; Program for Computational Biology & Bioinformatics, Yale University, New Haven, CT, USA; Program for Applied Math, Yale University, New Haven, CT, USA; Wu-Tsai Institute, Yale University, New Haven, CT, USA. Electronic address: smita.krishnaswamy@yale.edu., Tape CJ; Cell Communication Lab, Department of Oncology, University College London Cancer Institute, London WC1E 6DD, UK. Electronic address: c.tape@ucl.ac.uk.
Publikováno v:
Cell [Cell] 2023 Dec 07; Vol. 186 (25), pp. 5606-5619.e24.
Autor:
Bahri M; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London SE1 1UL, United Kingdom., Anstee JE; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London SE1 1UL, United Kingdom., Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London SE1 1UL, United Kingdom., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London SE1 1UL, United Kingdom.
Publikováno v:
Essays in biochemistry [Essays Biochem] 2023 Sep 28; Vol. 67 (6), pp. 919-928.
Autor:
Anstee JE; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Feehan KT; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Dean I; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Muller HP; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Bahri M; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Cheung TS; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Liakath-Ali K; Centre for Stem Cells and Regenerative Medicine, King's College London, London SE1 9RT, UK., Liu Z; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Choy D; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Caron J; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Sosnowska D; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Beatson R; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Muliaditan T; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., An Z; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Gillett CE; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Lan G; Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK., Zou X; Cancer Research UK Cambridge Research Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 ORE, UK., Watt FM; Centre for Stem Cells and Regenerative Medicine, King's College London, London SE1 9RT, UK., Ng T; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK; UCL Cancer Institute, University College London, London WC1E 6DD, UK., Burchell JM; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK; Haematology Department, Guy's Hospital, London SE1 9RT, UK., Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Lawrence T; Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King's College London, London SE1 1UL, UK; Aix Marseille University, CNRS, INSERM, CIML, Marseille, France; Henan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK. Electronic address: james.arnold@kcl.ac.uk.
Publikováno v:
Developmental cell [Dev Cell] 2023 Sep 11; Vol. 58 (17), pp. 1548-1561.e10. Date of Electronic Publication: 2023 Jul 12.
Autor:
Barber PR; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Mustapha R; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Flores-Borja F; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Alfano G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Ng K; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Weitsman G; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Dolcetti L; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Suwaidan AA; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Wong F; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Vicencio JM; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Galazi M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Opzoomer JW; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Arnold JN; Tumor Immunology Group, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Thavaraj S; Centre for Clinical, Oral & Translational Science, King's College London, London, United Kingdom., Kordasti S; Systems Cancer Immunology, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom., Doyle J; Daiichi Sankyo Incorporated, Newark, United States., Greenberg J; Daiichi Sankyo Incorporated, Newark, United States., Dillon MT; The Institute of Cancer Research, London, United Kingdom., Harrington KJ; The Institute of Cancer Research, London, United Kingdom., Forster M; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Coolen ACC; Institute for Mathematical and Molecular Biomedicine, King's College London, London, United Kingdom.; Saddle Point Science Ltd, London, United Kingdom., Ng T; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom.; Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.; Breast Cancer Now Research Unit, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom.
Publikováno v:
ELife [Elife] 2022 Dec 23; Vol. 11. Date of Electronic Publication: 2022 Dec 23.
Autor:
Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Anstee JE; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Dean I; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Hill EJ; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Bouybayoune I; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Caron J; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Muliaditan T; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Gordon P; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Sosnowska D; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Nuamah R; NIHR BRC Genomics Facility, Guy's and St Thomas' NHS Foundation Trust, King's College London, Guy's Hospital, London SE1 9RT, UK., Pinder SE; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Ng T; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK.; UCL Cancer Institute, University College London, London WC1E 6DD, UK., Dazzi F; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK., Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK.; Haematology Department, Guy's Hospital, London, SE1 9RT, UK., Withers DR; Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK., Lawrence T; Centre for Inflammation Biology and Cancer Immunology, School of Immunology & Microbial Sciences, King's College London, London SE1 1UL, UK.; Aix Marseille University, CNRS, INSERM, CIML, Marseille, France.; Henan Key Laboratory of Immunology and Targeted Therapy, School of Laboratory Medicine, Xinxiang Medical University, Xinxiang, China., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 1UL, UK.
Publikováno v:
Science advances [Sci Adv] 2021 Nov 05; Vol. 7 (45), pp. eabg9518. Date of Electronic Publication: 2021 Nov 03.
Autor:
Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Timms JA; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Blighe K; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Mourikis TP; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Chapuis N; Institut Cochin, Institut National de la Santé et de la Recherche Médicale U1016, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Université Paris Descartes, Paris, France., Bekoe R; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Kareemaghay S; Centre for Host Microbiome Interaction, FoDOCS, King's College, Guy's Hospital, London, United Kingdom., Nocerino P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Apollonio B; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Ramsay AG; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Tavassoli M; Centre for Host Microbiome Interaction, FoDOCS, King's College, Guy's Hospital, London, United Kingdom., Harrison C; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Haematology Department, Guy's Hospital, London, United Kingdom., Ciccarelli F; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Cancer Systems Biology Laboratory, The Francis Crick Institute, London, United Kingdom., Parker P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Francis Crick Institute, London, United Kingdom., Fontenay M; Institut Cochin, Institut National de la Santé et de la Recherche Médicale U1016, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 8104, Université Paris Descartes, Paris, France., Barber PR; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; UCL Cancer Institute, Paul O'Gorman Building, University College London, London, United Kingdom., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom., Kordasti S; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, United Kingdom.; Haematology Department, Guy's Hospital, London, United Kingdom.
Publikováno v:
ELife [Elife] 2021 Apr 30; Vol. 10. Date of Electronic Publication: 2021 Apr 30.
Autor:
Kosti P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Larios-Martinez KI; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Henley-Smith R; King's Health Partners Head and Neck Cancer Biobank, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK., Scudamore CL; ExePathology, Exmouth EX81TN, UK., Okesola M; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Taher MYM; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK.; Department of Laboratory Medicine, Taibah University, Medina 42353, Saudi Arabia., Davies DM; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Muliaditan T; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Larcombe-Young D; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Woodman N; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Gillett CE; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK., Thavaraj S; Centre for Oral, Clinical and Translational Sciences, King's College London, Guy's Campus, London SE1 9RT, UK., Maher J; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK.; Department of Immunology, Eastbourne Hospital, Kings Drive, Eastbourne, East Sussex BN21 2UD, UK.; Department of Clinical Immunology and Allergy, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, UK., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London SE1 1UL, UK.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2021 Apr 09; Vol. 2 (4), pp. 100227. Date of Electronic Publication: 2021 Apr 09 (Print Publication: 2021).
Autor:
Opzoomer JW; Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom., Sosnowska D; Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom., Anstee JE; Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom., Spicer JF; Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom., Arnold JN; Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, King's College London, Guy's Hospital, London, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 Jul 17; Vol. 10, pp. 1654. Date of Electronic Publication: 2019 Jul 17 (Print Publication: 2019).
Autor:
Muliaditan T; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Caron J; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Okesola M; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Opzoomer JW; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Kosti P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Georgouli M; Tumour Plasticity Laboratory, Randall Centre for Cell and Molecular Biophysics, King's College London, Guy's Campus, London, SE1 1UL, UK., Gordon P; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Lall S; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Kuzeva DM; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Pedro L; Medical Research Council Cancer Cell Unit, Hutchison/Medical Research Council Research Centre, Cambridge, CB2 0XZ, UK., Shields JD; Medical Research Council Cancer Cell Unit, Hutchison/Medical Research Council Research Centre, Cambridge, CB2 0XZ, UK., Gillett CE; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Diebold SS; National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, UK., Sanz-Moreno V; Tumour Plasticity Laboratory, Randall Centre for Cell and Molecular Biophysics, King's College London, Guy's Campus, London, SE1 1UL, UK., Ng T; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK., Hoste E; Unit for Cellular and Molecular Pathophysiology, VIB Center for Inflammation Research, B-9052, Ghent-Zwijnaarde, Belgium.; Department of Biomedical Molecular Biology, Ghent University, Ghent, B-9052, Belgium., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, Faculty of Life Sciences and Medicine, Guy's Campus, London, SE1 1UL, UK. james.n.arnold@kcl.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2018 Jul 27; Vol. 9 (1), pp. 2951. Date of Electronic Publication: 2018 Jul 27.